Total raised
—
Last: Undisclosed 2020-01
Stage
Seed
Founded
2016
Headcount
2
HQ
—
Sector
Health Tech & Life Sciences
About
Vvital Biomed is developing a technology for transcatheter mitral valve repair (TMVR). The companys solution is barely affected by the systolic pressure load or further annular dilatation due to continued remodeling, making the device stable and simplifying the TMVR procedure. Vvital Biomed joined Trendlines in December 2018.
Funding history · 1 round · — total
2020-01
Undisclosed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of Vvital Biomed's technology?
- Vvital Biomed is developing a technology for transcatheter mitral valve repair (TMVR).
- When was Vvital Biomed founded?
- Vvital Biomed was founded in December 2016.
- When did Vvital Biomed join Trendlines?
- Vvital Biomed joined Trendlines in December 2018.
- What is the current operational status of Vvital Biomed?
- Vvital Biomed is currently inactive, having ceased to operate in February 2022.
- Which investor participated in Vvital Biomed's undisclosed funding round in January 2020?
- The Trendlines Group was an investor in Vvital Biomed's undisclosed funding round in January 2020.
- What is the approximate employee count for Vvital Biomed?
- Vvital Biomed has an employee count in the range of 1-10, with an exact count of 2 employees.
- Who are the founders of Vvital Biomed?
- The founders of Vvital Biomed are Nir Golan and Aram K.Smolinsky.
- What is the primary sector classification for Vvital Biomed?
- Vvital Biomed's primary sector classification is Health Tech & Life Sciences.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
medical-technologiessurgerymedical-devicescardiologydoctorstreatments